TG Therapeutics Q1 2019 Earnings Report

Total Revenue
$38K
Previous year: $38K
+0.0%
EPS
-$0.43
Previous year: -$0.59
-27.1%
R&D Expense
$30.9M
SG&A Expense
$1.95M

TG Therapeutics

TG Therapeutics